Global Neonatal Seizures Drug Supply, Demand and Key Producers, 2023-2029
The global Neonatal Seizures Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Seizures in neonates are aberrant electrical discharges in the central nervous system that typically appear as stereotyped muscle activity or autonomic abnormalities. Electroencephalography confirms the diagnosis, and further testing for reasons is recommended. Treatment is determined by the underlying cause. Seizures affect up to 1.4 percent of full-term new-borns and 20% of premature infants. Seizures could be a sign of a significant neonatal condition that has to be evaluated right away. The lack of myelination and insufficient creation of dendrites and synapses in neonates prevents generalization of electrical activity, hence most neonatal seizures are focal.
This report studies the global Neonatal Seizures Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neonatal Seizures Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neonatal Seizures Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neonatal Seizures Drug total production and demand, 2018-2029, (K Units)
Global Neonatal Seizures Drug total production value, 2018-2029, (USD Million)
Global Neonatal Seizures Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neonatal Seizures Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Neonatal Seizures Drug domestic production, consumption, key domestic manufacturers and share
Global Neonatal Seizures Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Neonatal Seizures Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neonatal Seizures Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Neonatal Seizures Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Eisai Co., Ltd, AstraZeneca, Sanofi, Novartis AG, Abbott, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd and Pfizer Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neonatal Seizures Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neonatal Seizures Drug Market, By Region:
1. How big is the global Neonatal Seizures Drug market?
2. What is the demand of the global Neonatal Seizures Drug market?
3. What is the year over year growth of the global Neonatal Seizures Drug market?
4. What is the production and production value of the global Neonatal Seizures Drug market?
5. Who are the key producers in the global Neonatal Seizures Drug market?
6. What are the growth factors driving the market demand?
Seizures in neonates are aberrant electrical discharges in the central nervous system that typically appear as stereotyped muscle activity or autonomic abnormalities. Electroencephalography confirms the diagnosis, and further testing for reasons is recommended. Treatment is determined by the underlying cause. Seizures affect up to 1.4 percent of full-term new-borns and 20% of premature infants. Seizures could be a sign of a significant neonatal condition that has to be evaluated right away. The lack of myelination and insufficient creation of dendrites and synapses in neonates prevents generalization of electrical activity, hence most neonatal seizures are focal.
This report studies the global Neonatal Seizures Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neonatal Seizures Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neonatal Seizures Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neonatal Seizures Drug total production and demand, 2018-2029, (K Units)
Global Neonatal Seizures Drug total production value, 2018-2029, (USD Million)
Global Neonatal Seizures Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neonatal Seizures Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Neonatal Seizures Drug domestic production, consumption, key domestic manufacturers and share
Global Neonatal Seizures Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Neonatal Seizures Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neonatal Seizures Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Neonatal Seizures Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Eisai Co., Ltd, AstraZeneca, Sanofi, Novartis AG, Abbott, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd and Pfizer Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neonatal Seizures Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neonatal Seizures Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Dilantin
- Phenobarbital
- Other
- Tonic Seizures
- Clonic and Myoclonic Seizures
- Non Paroxysmal Repetitive Behaviours
- Other
- Merck KGaA
- Eisai Co., Ltd
- AstraZeneca
- Sanofi
- Novartis AG
- Abbott
- F. Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc
- GlaxoSmithKline plc
- WOCKHARDT
- Novo Nordisk A/S
- Glenmark Pharmaceuticals Limited
- Cipla Inc
- Bausch Health Companies Inc
- Otsuka America Pharmaceutical, Inc
- Johnson & Johnson Private Limited
- Takeda Pharmaceutical Company Limited
- Sumitomo Corporation
- Biocon
1. How big is the global Neonatal Seizures Drug market?
2. What is the demand of the global Neonatal Seizures Drug market?
3. What is the year over year growth of the global Neonatal Seizures Drug market?
4. What is the production and production value of the global Neonatal Seizures Drug market?
5. Who are the key producers in the global Neonatal Seizures Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neonatal Seizures Drug Introduction
1.2 World Neonatal Seizures Drug Supply & Forecast
1.2.1 World Neonatal Seizures Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Neonatal Seizures Drug Production (2018-2029)
1.2.3 World Neonatal Seizures Drug Pricing Trends (2018-2029)
1.3 World Neonatal Seizures Drug Production by Region (Based on Production Site)
1.3.1 World Neonatal Seizures Drug Production Value by Region (2018-2029)
1.3.2 World Neonatal Seizures Drug Production by Region (2018-2029)
1.3.3 World Neonatal Seizures Drug Average Price by Region (2018-2029)
1.3.4 North America Neonatal Seizures Drug Production (2018-2029)
1.3.5 Europe Neonatal Seizures Drug Production (2018-2029)
1.3.6 China Neonatal Seizures Drug Production (2018-2029)
1.3.7 Japan Neonatal Seizures Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neonatal Seizures Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neonatal Seizures Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neonatal Seizures Drug Demand (2018-2029)
2.2 World Neonatal Seizures Drug Consumption by Region
2.2.1 World Neonatal Seizures Drug Consumption by Region (2018-2023)
2.2.2 World Neonatal Seizures Drug Consumption Forecast by Region (2024-2029)
2.3 United States Neonatal Seizures Drug Consumption (2018-2029)
2.4 China Neonatal Seizures Drug Consumption (2018-2029)
2.5 Europe Neonatal Seizures Drug Consumption (2018-2029)
2.6 Japan Neonatal Seizures Drug Consumption (2018-2029)
2.7 South Korea Neonatal Seizures Drug Consumption (2018-2029)
2.8 ASEAN Neonatal Seizures Drug Consumption (2018-2029)
2.9 India Neonatal Seizures Drug Consumption (2018-2029)
3 WORLD NEONATAL SEIZURES DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neonatal Seizures Drug Production Value by Manufacturer (2018-2023)
3.2 World Neonatal Seizures Drug Production by Manufacturer (2018-2023)
3.3 World Neonatal Seizures Drug Average Price by Manufacturer (2018-2023)
3.4 Neonatal Seizures Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neonatal Seizures Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neonatal Seizures Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Neonatal Seizures Drug in 2022
3.6 Neonatal Seizures Drug Market: Overall Company Footprint Analysis
3.6.1 Neonatal Seizures Drug Market: Region Footprint
3.6.2 Neonatal Seizures Drug Market: Company Product Type Footprint
3.6.3 Neonatal Seizures Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neonatal Seizures Drug Production Value Comparison
4.1.1 United States VS China: Neonatal Seizures Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Neonatal Seizures Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Neonatal Seizures Drug Production Comparison
4.2.1 United States VS China: Neonatal Seizures Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neonatal Seizures Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Neonatal Seizures Drug Consumption Comparison
4.3.1 United States VS China: Neonatal Seizures Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Neonatal Seizures Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Neonatal Seizures Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neonatal Seizures Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Neonatal Seizures Drug Production (2018-2023)
4.5 China Based Neonatal Seizures Drug Manufacturers and Market Share
4.5.1 China Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neonatal Seizures Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Neonatal Seizures Drug Production (2018-2023)
4.6 Rest of World Based Neonatal Seizures Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neonatal Seizures Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Neonatal Seizures Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neonatal Seizures Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dilantin
5.2.2 Phenobarbital
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Neonatal Seizures Drug Production by Type (2018-2029)
5.3.2 World Neonatal Seizures Drug Production Value by Type (2018-2029)
5.3.3 World Neonatal Seizures Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neonatal Seizures Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tonic Seizures
6.2.2 Clonic and Myoclonic Seizures
6.2.3 Non Paroxysmal Repetitive Behaviours
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Neonatal Seizures Drug Production by Application (2018-2029)
6.3.2 World Neonatal Seizures Drug Production Value by Application (2018-2029)
6.3.3 World Neonatal Seizures Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck KGaA
7.1.1 Merck KGaA Details
7.1.2 Merck KGaA Major Business
7.1.3 Merck KGaA Neonatal Seizures Drug Product and Services
7.1.4 Merck KGaA Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck KGaA Recent Developments/Updates
7.1.6 Merck KGaA Competitive Strengths & Weaknesses
7.2 Eisai Co., Ltd
7.2.1 Eisai Co., Ltd Details
7.2.2 Eisai Co., Ltd Major Business
7.2.3 Eisai Co., Ltd Neonatal Seizures Drug Product and Services
7.2.4 Eisai Co., Ltd Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Eisai Co., Ltd Recent Developments/Updates
7.2.6 Eisai Co., Ltd Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca Neonatal Seizures Drug Product and Services
7.3.4 AstraZeneca Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Neonatal Seizures Drug Product and Services
7.4.4 Sanofi Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Novartis AG
7.5.1 Novartis AG Details
7.5.2 Novartis AG Major Business
7.5.3 Novartis AG Neonatal Seizures Drug Product and Services
7.5.4 Novartis AG Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis AG Recent Developments/Updates
7.5.6 Novartis AG Competitive Strengths & Weaknesses
7.6 Abbott
7.6.1 Abbott Details
7.6.2 Abbott Major Business
7.6.3 Abbott Neonatal Seizures Drug Product and Services
7.6.4 Abbott Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Abbott Recent Developments/Updates
7.6.6 Abbott Competitive Strengths & Weaknesses
7.7 F. Hoffmann-La Roche Ltd
7.7.1 F. Hoffmann-La Roche Ltd Details
7.7.2 F. Hoffmann-La Roche Ltd Major Business
7.7.3 F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Product and Services
7.7.4 F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.7.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Details
7.8.2 Teva Pharmaceutical Industries Ltd Major Business
7.8.3 Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Product and Services
7.8.4 Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.9 Pfizer Inc
7.9.1 Pfizer Inc Details
7.9.2 Pfizer Inc Major Business
7.9.3 Pfizer Inc Neonatal Seizures Drug Product and Services
7.9.4 Pfizer Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pfizer Inc Recent Developments/Updates
7.9.6 Pfizer Inc Competitive Strengths & Weaknesses
7.10 GlaxoSmithKline plc
7.10.1 GlaxoSmithKline plc Details
7.10.2 GlaxoSmithKline plc Major Business
7.10.3 GlaxoSmithKline plc Neonatal Seizures Drug Product and Services
7.10.4 GlaxoSmithKline plc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GlaxoSmithKline plc Recent Developments/Updates
7.10.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.11 WOCKHARDT
7.11.1 WOCKHARDT Details
7.11.2 WOCKHARDT Major Business
7.11.3 WOCKHARDT Neonatal Seizures Drug Product and Services
7.11.4 WOCKHARDT Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 WOCKHARDT Recent Developments/Updates
7.11.6 WOCKHARDT Competitive Strengths & Weaknesses
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Details
7.12.2 Novo Nordisk A/S Major Business
7.12.3 Novo Nordisk A/S Neonatal Seizures Drug Product and Services
7.12.4 Novo Nordisk A/S Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Novo Nordisk A/S Recent Developments/Updates
7.12.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.13 Glenmark Pharmaceuticals Limited
7.13.1 Glenmark Pharmaceuticals Limited Details
7.13.2 Glenmark Pharmaceuticals Limited Major Business
7.13.3 Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Product and Services
7.13.4 Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.13.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.14 Cipla Inc
7.14.1 Cipla Inc Details
7.14.2 Cipla Inc Major Business
7.14.3 Cipla Inc Neonatal Seizures Drug Product and Services
7.14.4 Cipla Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Cipla Inc Recent Developments/Updates
7.14.6 Cipla Inc Competitive Strengths & Weaknesses
7.15 Bausch Health Companies Inc
7.15.1 Bausch Health Companies Inc Details
7.15.2 Bausch Health Companies Inc Major Business
7.15.3 Bausch Health Companies Inc Neonatal Seizures Drug Product and Services
7.15.4 Bausch Health Companies Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Bausch Health Companies Inc Recent Developments/Updates
7.15.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.16 Otsuka America Pharmaceutical, Inc
7.16.1 Otsuka America Pharmaceutical, Inc Details
7.16.2 Otsuka America Pharmaceutical, Inc Major Business
7.16.3 Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Product and Services
7.16.4 Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Otsuka America Pharmaceutical, Inc Recent Developments/Updates
7.16.6 Otsuka America Pharmaceutical, Inc Competitive Strengths & Weaknesses
7.17 Johnson & Johnson Private Limited
7.17.1 Johnson & Johnson Private Limited Details
7.17.2 Johnson & Johnson Private Limited Major Business
7.17.3 Johnson & Johnson Private Limited Neonatal Seizures Drug Product and Services
7.17.4 Johnson & Johnson Private Limited Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Johnson & Johnson Private Limited Recent Developments/Updates
7.17.6 Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
7.18 Takeda Pharmaceutical Company Limited
7.18.1 Takeda Pharmaceutical Company Limited Details
7.18.2 Takeda Pharmaceutical Company Limited Major Business
7.18.3 Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Product and Services
7.18.4 Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.18.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.19 Sumitomo Corporation
7.19.1 Sumitomo Corporation Details
7.19.2 Sumitomo Corporation Major Business
7.19.3 Sumitomo Corporation Neonatal Seizures Drug Product and Services
7.19.4 Sumitomo Corporation Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Sumitomo Corporation Recent Developments/Updates
7.19.6 Sumitomo Corporation Competitive Strengths & Weaknesses
7.20 Biocon
7.20.1 Biocon Details
7.20.2 Biocon Major Business
7.20.3 Biocon Neonatal Seizures Drug Product and Services
7.20.4 Biocon Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Biocon Recent Developments/Updates
7.20.6 Biocon Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neonatal Seizures Drug Industry Chain
8.2 Neonatal Seizures Drug Upstream Analysis
8.2.1 Neonatal Seizures Drug Core Raw Materials
8.2.2 Main Manufacturers of Neonatal Seizures Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Neonatal Seizures Drug Production Mode
8.6 Neonatal Seizures Drug Procurement Model
8.7 Neonatal Seizures Drug Industry Sales Model and Sales Channels
8.7.1 Neonatal Seizures Drug Sales Model
8.7.2 Neonatal Seizures Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Neonatal Seizures Drug Introduction
1.2 World Neonatal Seizures Drug Supply & Forecast
1.2.1 World Neonatal Seizures Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Neonatal Seizures Drug Production (2018-2029)
1.2.3 World Neonatal Seizures Drug Pricing Trends (2018-2029)
1.3 World Neonatal Seizures Drug Production by Region (Based on Production Site)
1.3.1 World Neonatal Seizures Drug Production Value by Region (2018-2029)
1.3.2 World Neonatal Seizures Drug Production by Region (2018-2029)
1.3.3 World Neonatal Seizures Drug Average Price by Region (2018-2029)
1.3.4 North America Neonatal Seizures Drug Production (2018-2029)
1.3.5 Europe Neonatal Seizures Drug Production (2018-2029)
1.3.6 China Neonatal Seizures Drug Production (2018-2029)
1.3.7 Japan Neonatal Seizures Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neonatal Seizures Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neonatal Seizures Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neonatal Seizures Drug Demand (2018-2029)
2.2 World Neonatal Seizures Drug Consumption by Region
2.2.1 World Neonatal Seizures Drug Consumption by Region (2018-2023)
2.2.2 World Neonatal Seizures Drug Consumption Forecast by Region (2024-2029)
2.3 United States Neonatal Seizures Drug Consumption (2018-2029)
2.4 China Neonatal Seizures Drug Consumption (2018-2029)
2.5 Europe Neonatal Seizures Drug Consumption (2018-2029)
2.6 Japan Neonatal Seizures Drug Consumption (2018-2029)
2.7 South Korea Neonatal Seizures Drug Consumption (2018-2029)
2.8 ASEAN Neonatal Seizures Drug Consumption (2018-2029)
2.9 India Neonatal Seizures Drug Consumption (2018-2029)
3 WORLD NEONATAL SEIZURES DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neonatal Seizures Drug Production Value by Manufacturer (2018-2023)
3.2 World Neonatal Seizures Drug Production by Manufacturer (2018-2023)
3.3 World Neonatal Seizures Drug Average Price by Manufacturer (2018-2023)
3.4 Neonatal Seizures Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neonatal Seizures Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neonatal Seizures Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Neonatal Seizures Drug in 2022
3.6 Neonatal Seizures Drug Market: Overall Company Footprint Analysis
3.6.1 Neonatal Seizures Drug Market: Region Footprint
3.6.2 Neonatal Seizures Drug Market: Company Product Type Footprint
3.6.3 Neonatal Seizures Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neonatal Seizures Drug Production Value Comparison
4.1.1 United States VS China: Neonatal Seizures Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Neonatal Seizures Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Neonatal Seizures Drug Production Comparison
4.2.1 United States VS China: Neonatal Seizures Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neonatal Seizures Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Neonatal Seizures Drug Consumption Comparison
4.3.1 United States VS China: Neonatal Seizures Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Neonatal Seizures Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Neonatal Seizures Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neonatal Seizures Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Neonatal Seizures Drug Production (2018-2023)
4.5 China Based Neonatal Seizures Drug Manufacturers and Market Share
4.5.1 China Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neonatal Seizures Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Neonatal Seizures Drug Production (2018-2023)
4.6 Rest of World Based Neonatal Seizures Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neonatal Seizures Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Neonatal Seizures Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neonatal Seizures Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dilantin
5.2.2 Phenobarbital
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Neonatal Seizures Drug Production by Type (2018-2029)
5.3.2 World Neonatal Seizures Drug Production Value by Type (2018-2029)
5.3.3 World Neonatal Seizures Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neonatal Seizures Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tonic Seizures
6.2.2 Clonic and Myoclonic Seizures
6.2.3 Non Paroxysmal Repetitive Behaviours
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Neonatal Seizures Drug Production by Application (2018-2029)
6.3.2 World Neonatal Seizures Drug Production Value by Application (2018-2029)
6.3.3 World Neonatal Seizures Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck KGaA
7.1.1 Merck KGaA Details
7.1.2 Merck KGaA Major Business
7.1.3 Merck KGaA Neonatal Seizures Drug Product and Services
7.1.4 Merck KGaA Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck KGaA Recent Developments/Updates
7.1.6 Merck KGaA Competitive Strengths & Weaknesses
7.2 Eisai Co., Ltd
7.2.1 Eisai Co., Ltd Details
7.2.2 Eisai Co., Ltd Major Business
7.2.3 Eisai Co., Ltd Neonatal Seizures Drug Product and Services
7.2.4 Eisai Co., Ltd Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Eisai Co., Ltd Recent Developments/Updates
7.2.6 Eisai Co., Ltd Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca Neonatal Seizures Drug Product and Services
7.3.4 AstraZeneca Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Neonatal Seizures Drug Product and Services
7.4.4 Sanofi Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Novartis AG
7.5.1 Novartis AG Details
7.5.2 Novartis AG Major Business
7.5.3 Novartis AG Neonatal Seizures Drug Product and Services
7.5.4 Novartis AG Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis AG Recent Developments/Updates
7.5.6 Novartis AG Competitive Strengths & Weaknesses
7.6 Abbott
7.6.1 Abbott Details
7.6.2 Abbott Major Business
7.6.3 Abbott Neonatal Seizures Drug Product and Services
7.6.4 Abbott Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Abbott Recent Developments/Updates
7.6.6 Abbott Competitive Strengths & Weaknesses
7.7 F. Hoffmann-La Roche Ltd
7.7.1 F. Hoffmann-La Roche Ltd Details
7.7.2 F. Hoffmann-La Roche Ltd Major Business
7.7.3 F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Product and Services
7.7.4 F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.7.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Details
7.8.2 Teva Pharmaceutical Industries Ltd Major Business
7.8.3 Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Product and Services
7.8.4 Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.9 Pfizer Inc
7.9.1 Pfizer Inc Details
7.9.2 Pfizer Inc Major Business
7.9.3 Pfizer Inc Neonatal Seizures Drug Product and Services
7.9.4 Pfizer Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Pfizer Inc Recent Developments/Updates
7.9.6 Pfizer Inc Competitive Strengths & Weaknesses
7.10 GlaxoSmithKline plc
7.10.1 GlaxoSmithKline plc Details
7.10.2 GlaxoSmithKline plc Major Business
7.10.3 GlaxoSmithKline plc Neonatal Seizures Drug Product and Services
7.10.4 GlaxoSmithKline plc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GlaxoSmithKline plc Recent Developments/Updates
7.10.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.11 WOCKHARDT
7.11.1 WOCKHARDT Details
7.11.2 WOCKHARDT Major Business
7.11.3 WOCKHARDT Neonatal Seizures Drug Product and Services
7.11.4 WOCKHARDT Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 WOCKHARDT Recent Developments/Updates
7.11.6 WOCKHARDT Competitive Strengths & Weaknesses
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Details
7.12.2 Novo Nordisk A/S Major Business
7.12.3 Novo Nordisk A/S Neonatal Seizures Drug Product and Services
7.12.4 Novo Nordisk A/S Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Novo Nordisk A/S Recent Developments/Updates
7.12.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.13 Glenmark Pharmaceuticals Limited
7.13.1 Glenmark Pharmaceuticals Limited Details
7.13.2 Glenmark Pharmaceuticals Limited Major Business
7.13.3 Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Product and Services
7.13.4 Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.13.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.14 Cipla Inc
7.14.1 Cipla Inc Details
7.14.2 Cipla Inc Major Business
7.14.3 Cipla Inc Neonatal Seizures Drug Product and Services
7.14.4 Cipla Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Cipla Inc Recent Developments/Updates
7.14.6 Cipla Inc Competitive Strengths & Weaknesses
7.15 Bausch Health Companies Inc
7.15.1 Bausch Health Companies Inc Details
7.15.2 Bausch Health Companies Inc Major Business
7.15.3 Bausch Health Companies Inc Neonatal Seizures Drug Product and Services
7.15.4 Bausch Health Companies Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Bausch Health Companies Inc Recent Developments/Updates
7.15.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.16 Otsuka America Pharmaceutical, Inc
7.16.1 Otsuka America Pharmaceutical, Inc Details
7.16.2 Otsuka America Pharmaceutical, Inc Major Business
7.16.3 Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Product and Services
7.16.4 Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Otsuka America Pharmaceutical, Inc Recent Developments/Updates
7.16.6 Otsuka America Pharmaceutical, Inc Competitive Strengths & Weaknesses
7.17 Johnson & Johnson Private Limited
7.17.1 Johnson & Johnson Private Limited Details
7.17.2 Johnson & Johnson Private Limited Major Business
7.17.3 Johnson & Johnson Private Limited Neonatal Seizures Drug Product and Services
7.17.4 Johnson & Johnson Private Limited Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Johnson & Johnson Private Limited Recent Developments/Updates
7.17.6 Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
7.18 Takeda Pharmaceutical Company Limited
7.18.1 Takeda Pharmaceutical Company Limited Details
7.18.2 Takeda Pharmaceutical Company Limited Major Business
7.18.3 Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Product and Services
7.18.4 Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.18.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.19 Sumitomo Corporation
7.19.1 Sumitomo Corporation Details
7.19.2 Sumitomo Corporation Major Business
7.19.3 Sumitomo Corporation Neonatal Seizures Drug Product and Services
7.19.4 Sumitomo Corporation Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Sumitomo Corporation Recent Developments/Updates
7.19.6 Sumitomo Corporation Competitive Strengths & Weaknesses
7.20 Biocon
7.20.1 Biocon Details
7.20.2 Biocon Major Business
7.20.3 Biocon Neonatal Seizures Drug Product and Services
7.20.4 Biocon Neonatal Seizures Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Biocon Recent Developments/Updates
7.20.6 Biocon Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neonatal Seizures Drug Industry Chain
8.2 Neonatal Seizures Drug Upstream Analysis
8.2.1 Neonatal Seizures Drug Core Raw Materials
8.2.2 Main Manufacturers of Neonatal Seizures Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Neonatal Seizures Drug Production Mode
8.6 Neonatal Seizures Drug Procurement Model
8.7 Neonatal Seizures Drug Industry Sales Model and Sales Channels
8.7.1 Neonatal Seizures Drug Sales Model
8.7.2 Neonatal Seizures Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Neonatal Seizures Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Neonatal Seizures Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Neonatal Seizures Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Neonatal Seizures Drug Production Value Market Share by Region (2018-2023)
Table 5. World Neonatal Seizures Drug Production Value Market Share by Region (2024-2029)
Table 6. World Neonatal Seizures Drug Production by Region (2018-2023) & (K Units)
Table 7. World Neonatal Seizures Drug Production by Region (2024-2029) & (K Units)
Table 8. World Neonatal Seizures Drug Production Market Share by Region (2018-2023)
Table 9. World Neonatal Seizures Drug Production Market Share by Region (2024-2029)
Table 10. World Neonatal Seizures Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Neonatal Seizures Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Neonatal Seizures Drug Major Market Trends
Table 13. World Neonatal Seizures Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Neonatal Seizures Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Neonatal Seizures Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Neonatal Seizures Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Neonatal Seizures Drug Producers in 2022
Table 18. World Neonatal Seizures Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Neonatal Seizures Drug Producers in 2022
Table 20. World Neonatal Seizures Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Neonatal Seizures Drug Company Evaluation Quadrant
Table 22. World Neonatal Seizures Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Neonatal Seizures Drug Production Site of Key Manufacturer
Table 24. Neonatal Seizures Drug Market: Company Product Type Footprint
Table 25. Neonatal Seizures Drug Market: Company Product Application Footprint
Table 26. Neonatal Seizures Drug Competitive Factors
Table 27. Neonatal Seizures Drug New Entrant and Capacity Expansion Plans
Table 28. Neonatal Seizures Drug Mergers & Acquisitions Activity
Table 29. United States VS China Neonatal Seizures Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Neonatal Seizures Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Neonatal Seizures Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neonatal Seizures Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Neonatal Seizures Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Neonatal Seizures Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Neonatal Seizures Drug Production Market Share (2018-2023)
Table 37. China Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neonatal Seizures Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Neonatal Seizures Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Neonatal Seizures Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Neonatal Seizures Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Neonatal Seizures Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Neonatal Seizures Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Neonatal Seizures Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Neonatal Seizures Drug Production Market Share (2018-2023)
Table 47. World Neonatal Seizures Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Neonatal Seizures Drug Production by Type (2018-2023) & (K Units)
Table 49. World Neonatal Seizures Drug Production by Type (2024-2029) & (K Units)
Table 50. World Neonatal Seizures Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Neonatal Seizures Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Neonatal Seizures Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Neonatal Seizures Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Neonatal Seizures Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Neonatal Seizures Drug Production by Application (2018-2023) & (K Units)
Table 56. World Neonatal Seizures Drug Production by Application (2024-2029) & (K Units)
Table 57. World Neonatal Seizures Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Neonatal Seizures Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Neonatal Seizures Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Neonatal Seizures Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 62. Merck KGaA Major Business
Table 63. Merck KGaA Neonatal Seizures Drug Product and Services
Table 64. Merck KGaA Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck KGaA Recent Developments/Updates
Table 66. Merck KGaA Competitive Strengths & Weaknesses
Table 67. Eisai Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Eisai Co., Ltd Major Business
Table 69. Eisai Co., Ltd Neonatal Seizures Drug Product and Services
Table 70. Eisai Co., Ltd Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Eisai Co., Ltd Recent Developments/Updates
Table 72. Eisai Co., Ltd Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca Neonatal Seizures Drug Product and Services
Table 76. AstraZeneca Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Neonatal Seizures Drug Product and Services
Table 82. Sanofi Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 86. Novartis AG Major Business
Table 87. Novartis AG Neonatal Seizures Drug Product and Services
Table 88. Novartis AG Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis AG Recent Developments/Updates
Table 90. Novartis AG Competitive Strengths & Weaknesses
Table 91. Abbott Basic Information, Manufacturing Base and Competitors
Table 92. Abbott Major Business
Table 93. Abbott Neonatal Seizures Drug Product and Services
Table 94. Abbott Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Abbott Recent Developments/Updates
Table 96. Abbott Competitive Strengths & Weaknesses
Table 97. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 98. F. Hoffmann-La Roche Ltd Major Business
Table 99. F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Product and Services
Table 100. F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 102. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceutical Industries Ltd Major Business
Table 105. Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Product and Services
Table 106. Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 108. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 109. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Inc Major Business
Table 111. Pfizer Inc Neonatal Seizures Drug Product and Services
Table 112. Pfizer Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Inc Recent Developments/Updates
Table 114. Pfizer Inc Competitive Strengths & Weaknesses
Table 115. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 116. GlaxoSmithKline plc Major Business
Table 117. GlaxoSmithKline plc Neonatal Seizures Drug Product and Services
Table 118. GlaxoSmithKline plc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GlaxoSmithKline plc Recent Developments/Updates
Table 120. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 121. WOCKHARDT Basic Information, Manufacturing Base and Competitors
Table 122. WOCKHARDT Major Business
Table 123. WOCKHARDT Neonatal Seizures Drug Product and Services
Table 124. WOCKHARDT Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. WOCKHARDT Recent Developments/Updates
Table 126. WOCKHARDT Competitive Strengths & Weaknesses
Table 127. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 128. Novo Nordisk A/S Major Business
Table 129. Novo Nordisk A/S Neonatal Seizures Drug Product and Services
Table 130. Novo Nordisk A/S Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Novo Nordisk A/S Recent Developments/Updates
Table 132. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 133. Glenmark Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 134. Glenmark Pharmaceuticals Limited Major Business
Table 135. Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Product and Services
Table 136. Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 138. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 139. Cipla Inc Basic Information, Manufacturing Base and Competitors
Table 140. Cipla Inc Major Business
Table 141. Cipla Inc Neonatal Seizures Drug Product and Services
Table 142. Cipla Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Cipla Inc Recent Developments/Updates
Table 144. Cipla Inc Competitive Strengths & Weaknesses
Table 145. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 146. Bausch Health Companies Inc Major Business
Table 147. Bausch Health Companies Inc Neonatal Seizures Drug Product and Services
Table 148. Bausch Health Companies Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Bausch Health Companies Inc Recent Developments/Updates
Table 150. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 151. Otsuka America Pharmaceutical, Inc Basic Information, Manufacturing Base and Competitors
Table 152. Otsuka America Pharmaceutical, Inc Major Business
Table 153. Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Product and Services
Table 154. Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Otsuka America Pharmaceutical, Inc Recent Developments/Updates
Table 156. Otsuka America Pharmaceutical, Inc Competitive Strengths & Weaknesses
Table 157. Johnson & Johnson Private Limited Basic Information, Manufacturing Base and Competitors
Table 158. Johnson & Johnson Private Limited Major Business
Table 159. Johnson & Johnson Private Limited Neonatal Seizures Drug Product and Services
Table 160. Johnson & Johnson Private Limited Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Johnson & Johnson Private Limited Recent Developments/Updates
Table 162. Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
Table 163. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 164. Takeda Pharmaceutical Company Limited Major Business
Table 165. Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Product and Services
Table 166. Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 168. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 169. Sumitomo Corporation Basic Information, Manufacturing Base and Competitors
Table 170. Sumitomo Corporation Major Business
Table 171. Sumitomo Corporation Neonatal Seizures Drug Product and Services
Table 172. Sumitomo Corporation Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Sumitomo Corporation Recent Developments/Updates
Table 174. Biocon Basic Information, Manufacturing Base and Competitors
Table 175. Biocon Major Business
Table 176. Biocon Neonatal Seizures Drug Product and Services
Table 177. Biocon Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Neonatal Seizures Drug Upstream (Raw Materials)
Table 179. Neonatal Seizures Drug Typical Customers
Table 180. Neonatal Seizures Drug Typical Distributors
Table 1. World Neonatal Seizures Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Neonatal Seizures Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Neonatal Seizures Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Neonatal Seizures Drug Production Value Market Share by Region (2018-2023)
Table 5. World Neonatal Seizures Drug Production Value Market Share by Region (2024-2029)
Table 6. World Neonatal Seizures Drug Production by Region (2018-2023) & (K Units)
Table 7. World Neonatal Seizures Drug Production by Region (2024-2029) & (K Units)
Table 8. World Neonatal Seizures Drug Production Market Share by Region (2018-2023)
Table 9. World Neonatal Seizures Drug Production Market Share by Region (2024-2029)
Table 10. World Neonatal Seizures Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Neonatal Seizures Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Neonatal Seizures Drug Major Market Trends
Table 13. World Neonatal Seizures Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Neonatal Seizures Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Neonatal Seizures Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Neonatal Seizures Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Neonatal Seizures Drug Producers in 2022
Table 18. World Neonatal Seizures Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Neonatal Seizures Drug Producers in 2022
Table 20. World Neonatal Seizures Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Neonatal Seizures Drug Company Evaluation Quadrant
Table 22. World Neonatal Seizures Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Neonatal Seizures Drug Production Site of Key Manufacturer
Table 24. Neonatal Seizures Drug Market: Company Product Type Footprint
Table 25. Neonatal Seizures Drug Market: Company Product Application Footprint
Table 26. Neonatal Seizures Drug Competitive Factors
Table 27. Neonatal Seizures Drug New Entrant and Capacity Expansion Plans
Table 28. Neonatal Seizures Drug Mergers & Acquisitions Activity
Table 29. United States VS China Neonatal Seizures Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Neonatal Seizures Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Neonatal Seizures Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neonatal Seizures Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Neonatal Seizures Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Neonatal Seizures Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Neonatal Seizures Drug Production Market Share (2018-2023)
Table 37. China Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neonatal Seizures Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Neonatal Seizures Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Neonatal Seizures Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Neonatal Seizures Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Neonatal Seizures Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Neonatal Seizures Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Neonatal Seizures Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Neonatal Seizures Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Neonatal Seizures Drug Production Market Share (2018-2023)
Table 47. World Neonatal Seizures Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Neonatal Seizures Drug Production by Type (2018-2023) & (K Units)
Table 49. World Neonatal Seizures Drug Production by Type (2024-2029) & (K Units)
Table 50. World Neonatal Seizures Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Neonatal Seizures Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Neonatal Seizures Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Neonatal Seizures Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Neonatal Seizures Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Neonatal Seizures Drug Production by Application (2018-2023) & (K Units)
Table 56. World Neonatal Seizures Drug Production by Application (2024-2029) & (K Units)
Table 57. World Neonatal Seizures Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Neonatal Seizures Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Neonatal Seizures Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Neonatal Seizures Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 62. Merck KGaA Major Business
Table 63. Merck KGaA Neonatal Seizures Drug Product and Services
Table 64. Merck KGaA Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck KGaA Recent Developments/Updates
Table 66. Merck KGaA Competitive Strengths & Weaknesses
Table 67. Eisai Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Eisai Co., Ltd Major Business
Table 69. Eisai Co., Ltd Neonatal Seizures Drug Product and Services
Table 70. Eisai Co., Ltd Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Eisai Co., Ltd Recent Developments/Updates
Table 72. Eisai Co., Ltd Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca Neonatal Seizures Drug Product and Services
Table 76. AstraZeneca Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Neonatal Seizures Drug Product and Services
Table 82. Sanofi Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 86. Novartis AG Major Business
Table 87. Novartis AG Neonatal Seizures Drug Product and Services
Table 88. Novartis AG Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis AG Recent Developments/Updates
Table 90. Novartis AG Competitive Strengths & Weaknesses
Table 91. Abbott Basic Information, Manufacturing Base and Competitors
Table 92. Abbott Major Business
Table 93. Abbott Neonatal Seizures Drug Product and Services
Table 94. Abbott Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Abbott Recent Developments/Updates
Table 96. Abbott Competitive Strengths & Weaknesses
Table 97. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 98. F. Hoffmann-La Roche Ltd Major Business
Table 99. F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Product and Services
Table 100. F. Hoffmann-La Roche Ltd Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 102. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceutical Industries Ltd Major Business
Table 105. Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Product and Services
Table 106. Teva Pharmaceutical Industries Ltd Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 108. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 109. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 110. Pfizer Inc Major Business
Table 111. Pfizer Inc Neonatal Seizures Drug Product and Services
Table 112. Pfizer Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Pfizer Inc Recent Developments/Updates
Table 114. Pfizer Inc Competitive Strengths & Weaknesses
Table 115. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 116. GlaxoSmithKline plc Major Business
Table 117. GlaxoSmithKline plc Neonatal Seizures Drug Product and Services
Table 118. GlaxoSmithKline plc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GlaxoSmithKline plc Recent Developments/Updates
Table 120. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 121. WOCKHARDT Basic Information, Manufacturing Base and Competitors
Table 122. WOCKHARDT Major Business
Table 123. WOCKHARDT Neonatal Seizures Drug Product and Services
Table 124. WOCKHARDT Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. WOCKHARDT Recent Developments/Updates
Table 126. WOCKHARDT Competitive Strengths & Weaknesses
Table 127. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 128. Novo Nordisk A/S Major Business
Table 129. Novo Nordisk A/S Neonatal Seizures Drug Product and Services
Table 130. Novo Nordisk A/S Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Novo Nordisk A/S Recent Developments/Updates
Table 132. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 133. Glenmark Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 134. Glenmark Pharmaceuticals Limited Major Business
Table 135. Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Product and Services
Table 136. Glenmark Pharmaceuticals Limited Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 138. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 139. Cipla Inc Basic Information, Manufacturing Base and Competitors
Table 140. Cipla Inc Major Business
Table 141. Cipla Inc Neonatal Seizures Drug Product and Services
Table 142. Cipla Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Cipla Inc Recent Developments/Updates
Table 144. Cipla Inc Competitive Strengths & Weaknesses
Table 145. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 146. Bausch Health Companies Inc Major Business
Table 147. Bausch Health Companies Inc Neonatal Seizures Drug Product and Services
Table 148. Bausch Health Companies Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Bausch Health Companies Inc Recent Developments/Updates
Table 150. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 151. Otsuka America Pharmaceutical, Inc Basic Information, Manufacturing Base and Competitors
Table 152. Otsuka America Pharmaceutical, Inc Major Business
Table 153. Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Product and Services
Table 154. Otsuka America Pharmaceutical, Inc Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Otsuka America Pharmaceutical, Inc Recent Developments/Updates
Table 156. Otsuka America Pharmaceutical, Inc Competitive Strengths & Weaknesses
Table 157. Johnson & Johnson Private Limited Basic Information, Manufacturing Base and Competitors
Table 158. Johnson & Johnson Private Limited Major Business
Table 159. Johnson & Johnson Private Limited Neonatal Seizures Drug Product and Services
Table 160. Johnson & Johnson Private Limited Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Johnson & Johnson Private Limited Recent Developments/Updates
Table 162. Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
Table 163. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 164. Takeda Pharmaceutical Company Limited Major Business
Table 165. Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Product and Services
Table 166. Takeda Pharmaceutical Company Limited Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 168. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 169. Sumitomo Corporation Basic Information, Manufacturing Base and Competitors
Table 170. Sumitomo Corporation Major Business
Table 171. Sumitomo Corporation Neonatal Seizures Drug Product and Services
Table 172. Sumitomo Corporation Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Sumitomo Corporation Recent Developments/Updates
Table 174. Biocon Basic Information, Manufacturing Base and Competitors
Table 175. Biocon Major Business
Table 176. Biocon Neonatal Seizures Drug Product and Services
Table 177. Biocon Neonatal Seizures Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Neonatal Seizures Drug Upstream (Raw Materials)
Table 179. Neonatal Seizures Drug Typical Customers
Table 180. Neonatal Seizures Drug Typical Distributors
LIST OF FIGURES
Figure 1. Neonatal Seizures Drug Picture
Figure 2. World Neonatal Seizures Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neonatal Seizures Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 5. World Neonatal Seizures Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Neonatal Seizures Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Neonatal Seizures Drug Production Market Share by Region (2018-2029)
Figure 8. North America Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 9. Europe Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 10. China Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 11. Japan Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 12. Neonatal Seizures Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 15. World Neonatal Seizures Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 17. China Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 22. India Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Neonatal Seizures Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Neonatal Seizures Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Neonatal Seizures Drug Markets in 2022
Figure 26. United States VS China: Neonatal Seizures Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Neonatal Seizures Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neonatal Seizures Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Neonatal Seizures Drug Production Market Share 2022
Figure 30. China Based Manufacturers Neonatal Seizures Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Neonatal Seizures Drug Production Market Share 2022
Figure 32. World Neonatal Seizures Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Neonatal Seizures Drug Production Value Market Share by Type in 2022
Figure 34. Dilantin
Figure 35. Phenobarbital
Figure 36. Other
Figure 37. World Neonatal Seizures Drug Production Market Share by Type (2018-2029)
Figure 38. World Neonatal Seizures Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Neonatal Seizures Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Neonatal Seizures Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Neonatal Seizures Drug Production Value Market Share by Application in 2022
Figure 42. Tonic Seizures
Figure 43. Clonic and Myoclonic Seizures
Figure 44. Non Paroxysmal Repetitive Behaviours
Figure 45. Other
Figure 46. World Neonatal Seizures Drug Production Market Share by Application (2018-2029)
Figure 47. World Neonatal Seizures Drug Production Value Market Share by Application (2018-2029)
Figure 48. World Neonatal Seizures Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Neonatal Seizures Drug Industry Chain
Figure 50. Neonatal Seizures Drug Procurement Model
Figure 51. Neonatal Seizures Drug Sales Model
Figure 52. Neonatal Seizures Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Neonatal Seizures Drug Picture
Figure 2. World Neonatal Seizures Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neonatal Seizures Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 5. World Neonatal Seizures Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Neonatal Seizures Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Neonatal Seizures Drug Production Market Share by Region (2018-2029)
Figure 8. North America Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 9. Europe Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 10. China Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 11. Japan Neonatal Seizures Drug Production (2018-2029) & (K Units)
Figure 12. Neonatal Seizures Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 15. World Neonatal Seizures Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 17. China Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 22. India Neonatal Seizures Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Neonatal Seizures Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Neonatal Seizures Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Neonatal Seizures Drug Markets in 2022
Figure 26. United States VS China: Neonatal Seizures Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Neonatal Seizures Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neonatal Seizures Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Neonatal Seizures Drug Production Market Share 2022
Figure 30. China Based Manufacturers Neonatal Seizures Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Neonatal Seizures Drug Production Market Share 2022
Figure 32. World Neonatal Seizures Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Neonatal Seizures Drug Production Value Market Share by Type in 2022
Figure 34. Dilantin
Figure 35. Phenobarbital
Figure 36. Other
Figure 37. World Neonatal Seizures Drug Production Market Share by Type (2018-2029)
Figure 38. World Neonatal Seizures Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Neonatal Seizures Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Neonatal Seizures Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Neonatal Seizures Drug Production Value Market Share by Application in 2022
Figure 42. Tonic Seizures
Figure 43. Clonic and Myoclonic Seizures
Figure 44. Non Paroxysmal Repetitive Behaviours
Figure 45. Other
Figure 46. World Neonatal Seizures Drug Production Market Share by Application (2018-2029)
Figure 47. World Neonatal Seizures Drug Production Value Market Share by Application (2018-2029)
Figure 48. World Neonatal Seizures Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Neonatal Seizures Drug Industry Chain
Figure 50. Neonatal Seizures Drug Procurement Model
Figure 51. Neonatal Seizures Drug Sales Model
Figure 52. Neonatal Seizures Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
